Evidence map›Paper›PMID 27358660›Full record

ReviewCurrent fungal infection reports

Next-Generation Sequencing in the Mycology Lab.

Jan Zoll, Eveline Snelders, Paul E Verweij, Willem J G Melchers

Abstract readReview
In one paragraph

Review in Current fungal infection reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Mycobiome in the Gut: A Multiperspective Review.Mediators of inflammation · 2020
    Review
  11. First Genome Sequences of Two Multidrug-ResistantFrontiers in microbiology · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jan ZollDepartment of Medical Microbiology, Radboud University Medical Centre, Box 9101, 6500 HB Nijmegen, The Netherlands.
Eveline SneldersInstitut Pasteur, Unité de Mycologie Moléculaire, Paris, France.
Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Centre, Box 9101, 6500 HB Nijmegen, The Netherlands.
Willem J G MelchersDepartment of Medical Microbiology, Radboud University Medical Centre, Box 9101, 6500 HB Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New state-of-the-art techniques in sequencing offer valuable tools in both detection of mycobiota and in understanding of the molecular mechanisms of resistance against antifungal compounds and virulence. Introduction of new sequencing platform with enhanced capacity and a reduction in costs for sequence analysis provides a potential powerful tool in mycological diagnosis and research. In this review, we summarize the applications of next-generation sequencing techniques in mycology.

Indexed as

Clinical mycology lab issuesMycobiomeNext-generation sequencingResistanceReviewWhole genome sequencing

Identifiers

PMID27358660
PMCPMC4896977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.